How do you circumcise a nation? The Rwandan case study

BMC Medicine

Edward J Mills³  Nathan Ford¹  Jamie I Forrest⁴  Vincent Mutabazi² 

[1] Department of HIV/AIDS, World Health Organization, Geneva, Switzerland;Ministry of Health, Republic of Rwanda, Rwanda Biomedical Centre-Medical Research Centre, Kigali, Rwanda;Stanford Prevention Research Center, Stanford University, Stanford, USA;Global Evaluative Sciences, Calgary, Canada

关键词: Scale-up;    Combination prevention;    HIV/AIDS;    Rwanda;    Voluntary medical male circumcision;   

Others  :  1121411
DOI  :  10.1186/s12916-014-0184-4

 received in 2014-09-11, accepted in 2014-09-11,  发布年份 2014

【 摘 要 】

Voluntary medical male circumcision has been conclusively demonstrated to reduce the lifetime risk of male acquisition of HIV. The strategy has been adopted as a component of a comprehensive strategy towards achieving an AIDS-free generation. A number of countries in which prevalence of HIV is high and circumcision is low have been identified as a priority, where innovative approaches to scale-up are currently being explored. Rwanda, as one of the priority countries, has faced a number of challenges to successful scale-up. We discuss here how simplifications in the procedure, addressing a lack of healthcare infrastructure and mobilizing resources, and engaging communities of both men and women have permitted Rwanda to move forward with more optimism in its scale-up tactics. Examples from Rwanda are used to highlight how these barriers can and should be addressed.

【 授权许可】

   
2014 Mutabazi et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Fauci AS, Folkers GK: Toward an AIDS-free generation. JAMA 2012, 308:343-344.
• [2]Baeten JM, Donnell D, Kapiga SH, Ronald A, John-Stewart G, Inambao M, Manongi R, Vwalika B, Celum C: Male circumcision and risk of male-to-female HIV-1 transmission: a multinational prospective study in African HIV-1-serodiscordant couples. AIDS (London, England) 2010, 24:737-744.
• [3]Gray RH, Kiwanuka N, Quinn TC, Sewankambo NK, Serwadda D, Mangen FW, Lutalo T, Nalugoda F, Kelly R, Meehan M, Chen MZ, Li C, Wawer MJ: Male circumcision and HIV acquisition and transmission: cohort studies in Rakai, Uganda. Rakai Project Team. AIDS (London, England) 2000, 14:2371-2381.
• [4]Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A: Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med 2005, 2:e298. Public Library of Science
• [5]Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, Williams CF, Campbell RT, Ndinya-Achola JO: Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. The Lancet 2007, 369:643-656.
• [6]Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F, Kiwanuka N, Moulton LH, Chaudhary MA, Chen MZ, Sewankambo NK, Wabwire-Mangen F, Bacon MC, Williams CF, Opendi P, Reynolds SJ, Laeyendecker O, Quinn TC, Wawer MJ: Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. The Lancet 2007, 369:657-666.
• [7]Mills E, Cooper C, Anema A, Guyatt G: Male circumcision for the prevention of heterosexually acquired HIV infection: a meta-analysis of randomized trials involving 11,050 men. HIV Med 2008, 9:332-335.
• [8]Dickson KE, Tran NT, Samuelson JL, Njeuhmeli E, Cherutich P, Dick B, Farley T, Ryan C, Hankins CA: Voluntary medical male circumcision: a framework analysis of policy and program implementation in eastern and southern Africa. PLoS Med 2011, 8:e1001133. Public Library of Science
• [9]Njeuhmeli E, Forsythe S, Reed J, Opuni M, Bollinger L, Heard N, Castor D, Stover J, Farley T, Menon V, Hankins C: Voluntary medical male circumcision: modeling the impact and cost of expanding male circumcision for HIV prevention in eastern and southern Africa. PLoS Med 2011, 8:e1001132. Public Library of Science
• [10]Tobian AAR, Kacker S, Quinn TC: Male circumcision: a globally relevant but under-utilized method for the prevention of HIV and other sexually transmitted infections. Annu Rev Med 2014, 65:293-306.
• [11]RoRMo H: Rwanda HIV and AIDS National Strategic Plan, July 2013 - June 2018. Center RB, Kigali, Rwanda; 2013.
• [12]Mwandi Z, Murphy A, Reed J, Chesang K, Njeuhmeli E, Agot K, Llewellyn E, Kirui C, Serrem K, Abuya I, Loolpapit M, Mbayaki R, Kiriro N, Cherutich P, Muraguri N, Motoku J, Kioko J, Knight N, Bock N: Voluntary medical male circumcision: translating research into the rapid expansion of services in Kenya, 2008-2011. PLoS Med 2011, 8:e1001130. Public Library of Science
• [13][http://www.ncbi.nlm.nih.gov/pubmed/24056898] webcite McPherson DB, Balisanga HN, Mbabazi JK: Bridging the accountability divide: male circumcision planning in Rwanda as a case study in how to merge divergent operational planning approaches.Health Policy Plan 2013. [Epub ahead of print]. .
• [14]Uthman OA, Uthman OA, Popoola TA, Popoola TA, Uthman M, Uthman MMB, Aremu O, Aremu O: Economic evaluations of adult male circumcision for prevention of heterosexual acquisition of HIV in men in Sub-Saharan Africa: a systematic review. PLoS One 2010, 5:e9628. Public Library of Science
• [15]Lagarde E, Taljaard D, Puren A, Auvert B: High rate of adverse events following circumcision of young male adults with the Tara KLamp technique: a randomised trial in South Africa. S Afr Med J 2009, 99:163-169.
• [16]Schmitz RF, Abu Bakar MH, Omar ZH, Kamalanathan S, Schulpen TW, van der Werken C: Results of group-circumcision of Muslim boys in Malaysia with a new type of disposable clamp. Trop Doct 2001, 31:152-154.
• [17]Evaluation of two adult devices. Meeting report - Geneva, Switzerland. 2013.
• [18]Mutabazi V, Kaplan SA, Rwamasirabo E, Bitega JP, Ngeruka ML, Savio D, Karema C, Binagwaho A: HIV prevention: male circumcision comparison between a nonsurgical device to a surgical technique in resource-limited settings: a prospective, randomized, nonmasked trial. J Acquir Immune Defic Syndr 2012, 61:49-55.
• [19]Mutabazi V, Kaplan SA, Rwamasirabo E, Bitega JP, Ngeruka ML, Savio D, Karema C, Binagwaho A: One-arm, open-label, prospective, cohort field study to assess the safety and efficacy of the PrePex device for scale-up of nonsurgical circumcision when performed by nurses in resource-limited settings for HIV prevention. J Acquir Immune Defic Syndr 2013, 63:315-322.
• [20]Tshimanga M, Mutabazi V: Panel discussion, Devices: clinical profiles and acceptability. Update on PrePex studies in Zimbabwe & Rwanda. [http://pag.aids2012.org/session.aspx?s=98#3] webciteIAS 2013: 7th IAS Conference on HIV Pathogenesis, Treatment and Prevention June 30-July 3, 2013 Kuala Lumper 2013 2013. http://pag.aids2012.org/session.aspx?s=98#3
• [21]Kanyago S, Riding DM, Mutakooha E, de la Lopez OA, Siedner MJ: Shang ring versus forceps-guided adult male circumcision: a randomized, controlled effectiveness study in southwestern Uganda. J Acquir Immune Defic Syndr 2013, 64:130-133.
• [22]Kigozi G, Musoke S, Watya S: The Acceptability and Safety of the Shang Ring for Adult Male Circumcision in Rakai, Uganda. [http://pag.ias2013.org/session.aspx?s=30–2] webcite7th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) 30 June – 3 July 2013, Kuala Lumpur, Malaysia 2013 2013. http://pag.ias2013.org/session.aspx?s=30–2
• [23]Ford N, Chu K, Mills EJ: Safety of task-shifting for male medical circumcision: a systematic review and meta-analysis. AIDS 2012, 26:559-566.
• [24]Kigozi G, Musoke R, Watya S, Kighoma N, Ssebbowa P, Serwadda D, Nalugoda F, Makumbi F, Li P, Lee R, Goldstein M, Wawer M, Sewankambo N, Gray RH: The acceptability and safety of the shang ring for adult male circumcision in Rakai, Uganda. J Acquir Immune Defic Syndr 2013, 63:617-621.